glp-1 cardiovascular outcomes 2025 news of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice The cardiovascular effects of GLP-1

Member Spotlight Jared Before I started taking GLP-1 medication through Ro, I was prediabetic and on my way toward Type 2 diabetes

The first step to cloning the receptor required identifying and extracting the right genetic sequence from DNA

Foods that increase butyrate production Consuming foods with soluble fiber creates short-chain fatty acids like butyrate, which directly stimulates GLP-1 production

Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials

Dann wirst du Audible lieben

It found people taking tirzepatide for type 2 diabetes lost as much as 12 pounds more than people taking a 1-milligram dose of semaglutide for 40 weeks